Search research articles
Contact Us
Filters
Showing results (71-80 of 81) with videos related to
Page
of 9
Sort By:
JCSM Communications
|
July 14, 2025
Intramuscular CMT-167 Tumors Produce a Mild Cachexia Phenotype in C57BL/6J Mice
Bryan C Remaily, Trang T Vu, Justin Thomas, et al.
JCSM Rapid Communications
|
September 13, 2021
Murine cancer cachexia models replicate elevated catabolic pembrolizumab clearance in humans
Alyssa Marie M Castillo, Trang T Vu, Sophia G Liva, et al.
Frontiers in Immunology
|
April 16, 2026
Fc gamma receptor binding modulates IgG clearance in cancer cachexia
Bryan C Remaily, Kyeongmin Kim, Justin Thomas, et al.
Cancers
|
February 27, 2026
A Novel Mouse Model to Identify Antigen-Specific Immune Responses in Pancreatic Cancer Cachexia
Ayushi Das, Debasmita Mukherjee, Liliana D'Alesio, et al.
Critical Care Medicine
|
December 10, 2024
Sex-Specific Obesity Paradox in Critically Ill Patients With Severe Acute Kidney Injury: A Retrospective Analysis
Hyo Jin Jung, Yu Jin Seo, Jiyun Jung, et al.
Pharmacological Research
|
December 25, 2023
Decoupling FcRn and tumor contributions to elevated immune checkpoint inhibitor clearance in cancer cachexia
Trang T Vu, Kyeongmin Kim, Millennium Manna, et al.
International Immunopharmacology
|
May 8, 2026
FcRn function alone cannot account for elevated IgG clearance in the Lewis lung carcinoma model of cancer cachexia
Adeoluwa Adeluola, Justin Thomas, Bryan Remaily, et al.
International Journal of Molecular Sciences
|
July 9, 2022
The Neonatal Fc Receptor Is Elevated in Monocyte-Derived Immune Cells in Pancreatic Cancer
Justin Thomas, Molly A Torok, Kriti Agrawal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 30, 2026
A randomized phase 2 study of combination atezolizumab and varlilumab (CDX-1127) with or without cobimetinib in previously-treated unresectable biliary tract cancer
Thatcher Ross Heumann, Jiayun Lu, Hao Wang, et al.
Frontiers in Immunology
|
January 2, 2026
Tumor intrinsic properties dictate Fc receptor expression and cancer cachexia associated increase in checkpoint inhibitor clearance
Bryan C Remaily, Greg Young, Hannah Lathrop, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 81) with videos related to
Sort By:
Page
of 9
JCSM Communications
|
July 14, 2025
Intramuscular CMT-167 Tumors Produce a Mild Cachexia Phenotype in C57BL/6J Mice
Bryan C Remaily, Trang T Vu, Justin Thomas, et al.
JCSM Rapid Communications
|
September 13, 2021
Murine cancer cachexia models replicate elevated catabolic pembrolizumab clearance in humans
Alyssa Marie M Castillo, Trang T Vu, Sophia G Liva, et al.
Frontiers in Immunology
|
April 16, 2026
Fc gamma receptor binding modulates IgG clearance in cancer cachexia
Bryan C Remaily, Kyeongmin Kim, Justin Thomas, et al.
Cancers
|
February 27, 2026
A Novel Mouse Model to Identify Antigen-Specific Immune Responses in Pancreatic Cancer Cachexia
Ayushi Das, Debasmita Mukherjee, Liliana D'Alesio, et al.
Critical Care Medicine
|
December 10, 2024
Sex-Specific Obesity Paradox in Critically Ill Patients With Severe Acute Kidney Injury: A Retrospective Analysis
Hyo Jin Jung, Yu Jin Seo, Jiyun Jung, et al.
Pharmacological Research
|
December 25, 2023
Decoupling FcRn and tumor contributions to elevated immune checkpoint inhibitor clearance in cancer cachexia
Trang T Vu, Kyeongmin Kim, Millennium Manna, et al.
International Immunopharmacology
|
May 8, 2026
FcRn function alone cannot account for elevated IgG clearance in the Lewis lung carcinoma model of cancer cachexia
Adeoluwa Adeluola, Justin Thomas, Bryan Remaily, et al.
International Journal of Molecular Sciences
|
July 9, 2022
The Neonatal Fc Receptor Is Elevated in Monocyte-Derived Immune Cells in Pancreatic Cancer
Justin Thomas, Molly A Torok, Kriti Agrawal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 30, 2026
A randomized phase 2 study of combination atezolizumab and varlilumab (CDX-1127) with or without cobimetinib in previously-treated unresectable biliary tract cancer
Thatcher Ross Heumann, Jiayun Lu, Hao Wang, et al.
Frontiers in Immunology
|
January 2, 2026
Tumor intrinsic properties dictate Fc receptor expression and cancer cachexia associated increase in checkpoint inhibitor clearance
Bryan C Remaily, Greg Young, Hannah Lathrop, et al.
Page
of 9